HAP's Latest News

October 15, 2021

What to Expect During an Unpredictable Flu Season

While we’ve always been able to count on our flu strategies, here comes the curveball. COVID-19 has changed the landscape for infectious disease planning, mitigation, and response. Interest in public health is at an all-time high as people seek out information to make health decisions from reliable and not-so-reliable sources. This winter, hospitals could face a potential flu epidemic on top of their COVID-19 caseloads.

October 14, 2021

FDA Panel OKs Moderna Booster for High-Risk Groups

The U.S. Food and Drug Administration’s (FDA) advisory panel recommended approving a half-dose booster of Moderna’s COVID-19 vaccine for older Americans, health care workers, and other high-risk groups.

October 06, 2021

FDA Panel to Evaluate Moderna, J&J Booster Doses

Next week, the U.S. Food and Drug Administration (FDA) will evaluate the next steps for Moderna and Johnson & Johnson’s COVID-19 booster doses, as well as available research about mixing vaccine brands.

123456Last


+